EPO Use OK In All But Eight Cancer Conditions, Medicare NCD Says
Final National Coverage Determination issued July 30 drops number of restricted uses of erythropoiesis-stimulating agents from the 13 listed in the draft NCD.
Final National Coverage Determination issued July 30 drops number of restricted uses of erythropoiesis-stimulating agents from the 13 listed in the draft NCD.